Chemoinformaics analysis of 3-phosphoglyceric acid
Molecular Weight | 186.056 | nRot | 4 |
Heavy Atom Molecular Weight | 179 | nRig | 3 |
Exact Molecular Weight | 185.993 | nRing | 0 |
Solubility: LogS | -0.041 | nHRing | 0 |
Solubility: LogP | -2.176 | No. of Aliphatic Rings | 0 |
Acid Count | 3 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 3 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 18.9216 |
nHD | 4 | BPOL | 18.3344 |
QED | 0.347 |
Synth | 4.975 |
Natural Product Likeliness | 0.158 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.088 |
HIA | 0.135 |
CACO-2 | -5.791 |
MDCK | 0.00663441 |
BBB | 0.707 |
PPB | 0.111476 |
VDSS | 0.349 |
FU | 0.905226 |
CYP1A2-inh | 0.002 |
CYP1A2-sub | 0.063 |
CYP2c19-inh | 0.031 |
CYP2c19-sub | 0.045 |
CYP2c9-inh | 0.01 |
CYP2c9-sub | 0.18 |
CYP2d6-inh | 0.02 |
CYP2d6-sub | 0.12 |
CYP3a4-inh | 0.004 |
CYP3a4-sub | 0.008 |
CL | 1.403 |
T12 | 0.925 |
hERG | 0.008 |
Ames | 0.172 |
ROA | 0.011 |
SkinSen | 0.798 |
Carcinogencity | 0.185 |
EI | 0.991 |
Respiratory | 0.677 |
NR-Aromatase | 0.001 |
Antiviral | No |
Prediction | 0.901003 |